Long-term study of mitochondrial replacement therapy in monkeys finds no adverse health effects
December 08, 2020
Findings add safety, efficacy support for gene therapy developed at OHSU.
Stories
Damage to brain cells reverberates to ‘bystander’ cells, study finds
December 08, 2020
OHSU scientists are first to document mechanism that can cause temporary but severe loss of nervous system function.
OHSU adjusts low-barrier test sites for COVID-19
December 07, 2020
First two hours daily will be reserved for priority groups.
OHSU physician honored for co-invention of eye-imaging technology
December 04, 2020
David Huang, M.D., Ph.D., recognized by Sanford and Susan Greenberg Prize to End Blindness.
New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations
December 03, 2020
Primary factor is heightened risk of exposure, transmission.
Local couples join male birth control study at OHSU
December 03, 2020
NES/T gel may expand contraceptive options, shared family planning responsibility.
Acclaimed OHSU HIV researcher appointed to COVID-19 vaccine review group
December 03, 2020
Gov. Kate Brown has named Louis Picker, M.D., to the Western States’ Scientific Safety Review Workgroup.
OHSU statement on Governor Kate Brown’s 2021-23 recommended budget
December 01, 2020
We are grateful for the Governor’s commitment to OHSU, the state’s only public academic health center. We know Governor Brown faced difficult choices in this budget and we applaud her efforts to limit reductions in public education during this...
El ensayo de la vacuna contra el COVID-19 recluta residentes del área metropolitana de Portland
November 30, 2020
OHSU es el único centro de Oregón para el ensayo clínico en fase 3 elaborado por AstraZeneca, Universidad de Oxford.
COVID-19 vaccine trial recruits Portland metro area residents
November 30, 2020
OHSU is the only Oregon site for Phase 3 clinical trial by AstraZeneca, Oxford University.
